Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Selma Bozcan"'
Publikováno v:
Annals of Hepatology, Vol 13, Iss 6, Pp 843-844 (2014)
Externí odkaz:
https://doaj.org/article/27698c0561dd4a5491389c74d1b184bc
Autor:
Abdullah, Sonsuz, Selma, Bozcan, İbrahim, Hatemi, Sebati, Özdemir, Billur, Canbakan, Süleyman, Yıldırım, İlkay, Gültürk, Cem, Ar
Publikováno v:
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 33(5)
Hepatitis C is one of the leading causes of death in patients with inherited bleeding disorders. Currently, direct-acting antiviral drugs used for the treatment of hepatitis C have become an effective and a reliable option for people with inherited b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cebe01c396d2fdd50f332e01cd036904
https://pubmed.ncbi.nlm.nih.gov/35678799
https://pubmed.ncbi.nlm.nih.gov/35678799
Autor:
Yusuf Erzin, Nurhan Demir, Sinem Celik, Tugce Eskazan, Ibrahim Hatemi, Suleyman Yildirim, Aykut Ferhat Celik, Selma Bozcan, Kadri Atay, Murat Tuncer
Publikováno v:
Pancreas. 50(9)
OBJECTIVE The aim of the study was to identify the frequency of azathioprine-induced acute pancreatitis (AZA-AP) and related factors. METHODS Seven hundred eighty-seven inflammatory bowel disease (IBD) patients on AZA therapy were retrospectively ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c746d4a2187512c12d66374609205f7
https://pubmed.ncbi.nlm.nih.gov/34860811
https://pubmed.ncbi.nlm.nih.gov/34860811
Autor:
Yusuf Erzin, Tugce Eskazan, Kadri Atay, Aykut Ferhat Celik, Selma Bozcan, Ibrahim Hatemi, Hayyam Eyvazov, Nurhan Demir
Hatemi, Ali Ibrahim/0000-0002-8385-9253; WOS:000474444300003 PubMed ID: 31290746 Background/Aims: The aim of the present study was to compare the demographic features and long-term outcomes of patients with inflammatory bowel disease (IBD) with or wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c07662fc7b84264597a317a40452727
https://doi.org/10.5152/tjg.2019.17291
https://doi.org/10.5152/tjg.2019.17291
Autor:
Umut Yilmaz, Nergis Serin, Suleyman Yildirim, Muhlis Cem Ar, Selma Bozcan, Veysel Sabri Hancer, Aykut Ferhat Celik, Ayse Salihoglu, Nukhet Tuzuner
16th International Symposium on Amyloidosis (ISA) -- MAR 26-29, 2018 -- Kumamoto, JAPAN Hereditary transthyretin-mediated amyloidosis (hATTR) is a rare, systemic and progressive autosomal dominant disease caused by mutations in the TTR gene. Systemic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd0e7bd200a394f41b13bb88ccfcbed2
https://hdl.handle.net/20.500.12713/645
https://hdl.handle.net/20.500.12713/645
Autor:
Oguz Kagan Bakkaloglu, F Celik, Ali İbrahim Hatemi, Suleyman Yildirim, Selma Bozcan, Yusuf Erzin, Tugce Eskazan, Enes Ali Kurt
Publikováno v:
Journal of Crohn's and Colitis. 14:S240-S240
Background Although faecal calprotectin can predict mucosal remission in ulcerative colitis, the CRP level in this context is insufficient and frequently stay under the current cut off level. While some patients with active mucosal disease have norma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a152d55d5030b480182de5851b9c765e
https://doi.org/10.1093/ecco-jcc/jjz203.333
https://doi.org/10.1093/ecco-jcc/jjz203.333
Publikováno v:
Pituitary. 18:554-560
We aimed to evaluate the disease activity of medically controlled patients with acromegaly after withdrawal of somatostatin receptor ligands (SRL). Sixteen patients who were on a stable dose of SRL for more than 2 years and had at least 1 year of rem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::807de58fdc0f769bcca359d9496577bf
https://doi.org/10.1007/s11102-014-0608-3
https://doi.org/10.1007/s11102-014-0608-3
Autor:
Yusuf Erzin, Nurhan Demir, Aykut Ferhat Celik, Ibrahim Hatemi, Suleyman Yildirim, Selma Bozcan
Publikováno v:
Journal of Crohn's and Colitis. 11:S221-S222
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d4690c437365f0d1c16029503cb9b9d
https://doi.org/10.1093/ecco-jcc/jjx002.407
https://doi.org/10.1093/ecco-jcc/jjx002.407
Autor:
Yusuf Erzin, Nurhan Demir, Suleyman Yildirim, Ibrahim Hatemi, Selma Bozcan, Aykut Ferhat Celik
Publikováno v:
Journal of Crohn's and Colitis. 11:S185-S186
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d5d902458ba81e3962e15211f0da860
https://doi.org/10.1093/ecco-jcc/jjx002.339
https://doi.org/10.1093/ecco-jcc/jjx002.339
Autor:
Yusuf Erzin, Aykut Ferhat Celik, Nurhan Demir, Ibrahim Hatemi, Suleyman Yildirim, Selma Bozcan
Publikováno v:
Journal of Crohn's and Colitis. 11:S427-S427
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef726878f3fdd6bfaa9d37875a40e578
https://doi.org/10.1093/ecco-jcc/jjx002.802
https://doi.org/10.1093/ecco-jcc/jjx002.802